The Role of Furosemide Stress Test in the Intensive Care Clinic
Recruiting
N/A
Interventional Study
Akut Kidney Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 140 (estimated)
- Sponsor
- Gulhane Training and Research Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
AKI causes high mortality and morbidity, especially in critically ill patients, and prolongs the patient's stay in the intensive care unit. Due to the high morbidity and mortality associated with AKI, many researchers are studying several new biomarkers for earlier detection of AKI, determination of etiologies, and prediction of outcomes. However, the use of these new biomarkers may be limited due…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Those who meet KDIGO AKI stage 1 and stage 2 criteria in the first 24 hours
2. Those with sufficient fluid volume (CVP≥6 cmH20)
3. Female and male patients over the age of 18 will be included in the study
Exclusion Criteria:
1. Pregnant patients
2. Hospitalization due to in…
Contacts